Stada to acquire established OTC portfolio in PH
Credit to Author: The Manila Times| Date: Fri, 21 Feb 2020 02:09:04 +0000
AFTER announcing a number of acquisitions and partnerships in Europe recently, the Stada Group is also expanding its over-the-counter (OTC) portfolio in the Asia-Pacific region. As the global manufacturer of high-quality generic drugs and consumer healthcare products announced today, Stada is acquiring the Philippine portfolio of FERN, one of the leading brands in the growing local vitamin C market.The product range consists of FERN-C, a vitamin C product that has been in the market for 15 years, as well as FERN-C Kidz and Kiddimin, two vitamin products for children.
Stada has had a long history of selling pharmaceuticals in the Philippines, formerly through Croma Medic Inc., which was acquired by Stada in early 2000 and recently renamed Stada Philippines.
“The acquisition of FERN will help us to succeed. The acquisition of these products is in line with our strategy to strengthen our portfolio with well-established consumer healthcare brands and also expand in selected emerging markets,” states Stada Chief Executive Officer Peter Goldschmidt.
“It will further Stada’s vision to be a trusted partner that provides high-quality, holistic care for the people. With both Stada and Fern carrying heritage, we will be able to provide better health for Filipinos,“ declares Stada Asia Pacific Managing Director Gary Clark.
Sharmaine Abarientos, Stada Philippines general manager adds, “We are able to offer quality medicines at reasonable prices across all segments of healthcare: specialty, generics and consumer health.”